KRISHNAMOHAN NEHA (Chief Financial Officer) reported 1 transaction at KINNATE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/5/2024ACC: 0001415889-24-006755
Officer· Chief Financial Officer
Since Jun 2021
-1.51K
Net shares
Net seller
$3.9K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.51K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.51K
Price / share
$2.59
Trade value
$3.90K
% of position
2.3%
3/1/2024
65.59K→64.09K
Total
Net shares
−1.51K
Net value
-$3.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2024 | F · Tax Withholding | −1.51K | $2.59 | $3.90K | 2.3% | 65.59K | 64.09K |
| Total | −1.51K | -$3.90K | ||||||
Derivative Transactions0
No derivative transactions reported